Últimos Artículos de Diabetes, Obesity and Metabolism
- Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
- The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials
- Effect of nutrition on postprandial glucose control in hospitalized patients with type 2 diabetes receiving fully automated closed‐loop insulin therapy
- Patient‐reported outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes
- Evidence‐Based Weight Loss Interventions: Individualized Treatment Options to Maximize Patient Outcomes
- Obesity as a risk factor for COVID‐19 mortality in women and men in the UK Biobank: comparisons with influenza/pneumonia and coronary heart disease
- Association between visit‐to‐visit hemoglobin A1c variability and the risk of cardiovascular disease in patients with type 2 diabetes
- Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists
- Efficacy and safety of polyethylene glycol loxenatide (PEX168) monotherapy in type 2 diabetes patients: a multicenter, randomized, double‐blind, placebo‐controlled, phase 3a clinical trial
- Short‐term intestinal lipase inhibition in normal‐weight individuals does not affect postprandial peptide YY3‐36 and glucagon‐like peptide‐1 levels, hunger or satiety
- Machine‐learning–based early prediction of end‐stage renal disease in patients with diabetic kidney disease using clinical trials data
- Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58
- Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes
- Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study
- Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation
- Sodium‐Glucose Co‐transporter‐2 Inhibition and ocular outcomes in patients with Type 2 Diabetes: A Systematic Review and Meta‐Analysis
- Effects of hyperglycaemia on complications of COVID‐19: A meta‐analysis of observational studies
- A look to the future in non‐alcoholic fatty liver disease: Are GLP‐1 analogues or SGLT‐2 inhibitors the answer?
- Obesity COVID‐19 patients show more severe pneumonia lesions on CT chest imaging
- Adherence and Persistence among Patients with Type 2 Diabetes Initiating Dulaglutide compared with Semaglutide and Exenatide BCise: 6‐month Follow‐up from US Real‐World Data